In line with PABPC4 acting together with HNRNPC, lower PABPC4 expression was associated with worse prognostic metrics and disease progression in breast cancer patient cohorts (Fig. 6f,g and Extended Data Fig. 6h). This evidence concerns the gene HNRNPC and breast carcinoma.